Suchergebnisse - "COVID-19 treatment"

PubPharm (330)

41

Hamburg Edoxaban foR anticoagulation in COvid-19 study : Hamburg Edoxaban foR anticoagulation in COvid-19 study - HERO-19

enthalten in: WHO International Clinical Trials Registry Platform | 2023

42

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People with Weakened Immune Systems or at Increased Risk for Poor Outcomes who are Hospitalized Due to Severe COVID-19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2, DOUBLE BLIND, 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED NIRMATRELVIR/RITONAVIR COMPARED WITH PLACEBO/RITONAVIR FOR THE TREATMENT OF SEVERE COVID-19 IN HOSPITALIZED PARTICIPANTS WHO ARE IMMUNOCOMPROMISED OR AT INCREASED RISK FOR SEVERE COVID-19 OUTCOMES

enthalten in: WHO International Clinical Trials Registry Platform | 2023

43

An economical and practical procedure of favipiravir synthesis for the treatment of Covid-19

enthalten in: Chemicke zvesti | 2023

von Karatas, H. | Hanashalshahaby, E. | Catal, U. | +5

44

Analytical Methods for the Determination of Major Drugs Used for the Treatment of COVID-19. A Review

enthalten in: Critical reviews in analytical chemistry | 2023

von Da Ruos, J. | Baldo, M. | Daniele, S.

45

Safety profile and clinical results of Remdesivir in Hemodialysis patients infected with SARS-CoV-2. A single-center Spanish cohort study

enthalten in: Journal of nephrology | 2023

von Cuadrado-Payán, E. | Rodríguez-Espinosa, D. | Broseta, J. | +2

46

Promising Repurposed Antiviral Molecules to Combat SARS-CoV-2 : A Review

enthalten in: Current pharmaceutical biotechnology | 2023

von Ratan, Y. | Rajput, A. | Jain, V. | +3

47

Short Title: Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC)INSIGHT 012 : An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19 - Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC)

enthalten in: WHO International Clinical Trials Registry Platform | 2023

48

A Study to Learn About a Repeat 5-Day Treatment with Nirmatrelvir/Ritonavir in People with Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment with Nirmatrelvir/Ritonavir : AN INTERVENTIONAL, EFFICACY AND SAFETY, PHASE 2, RANDOMIZED, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE A REPEAT 5-DAY COURSE OF NIRMATRELVIR/RITONAVIR COMPARED TO PLACEBO/RITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID-19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY

enthalten in: WHO International Clinical Trials Registry Platform | 2023

49

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People with Weakened Immune Systems or at Increased Risk for Poor Outcomes who are Hospitalized Due to Severe COVID-19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2, DOUBLE BLIND, 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED NIRMATRELVIR/RITONAVIR COMPARED WITH PLACEBO/RITONAVIR FOR THE TREATMENT OF SEVERE COVID-19 IN HOSPITALIZED PARTICIPANTS WHO ARE IMMUNOCOMPROMISED OR AT INCREASED RISK FOR SEVERE COVID-19 OUTCOMES

enthalten in: WHO International Clinical Trials Registry Platform | 2023

50

Evaluation of the efficacy and safety of a polyclonal equine fragments immunotherapy (FBR-002) in participants with COVID-19 requiring supplemental oxygen in hospital and at risk of severe outcome : A phase IIb randomized, placebo-controlled, double-blind study, to evaluate the efficacy and safety of FBR-002 in participants hospitalized with COVID-19 in need of supplemental oxygen and at risk of severe outcome

enthalten in: WHO International Clinical Trials Registry Platform | 2023